Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment

Clin Oncol (R Coll Radiol). 2014 Jun;26(6):357. doi: 10.1016/j.clon.2014.02.010. Epub 2014 Mar 12.

Authors

K Nakano¹, L Inagaki¹, J Tomomatsu¹, N Motoi², T Gokita¹, K Ae¹, T Tanizawa¹, T Shimoji¹, S Matsumoto¹, S Takahashi¹

Affiliations

¹ Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
² The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.

PMID: 24630810
DOI: 10.1016/j.clon.2014.02.010

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Angiogenesis Inhibitors / adverse effects*
Humans
Incidence
Indazoles
Male
Middle Aged
Pneumothorax / chemically induced*
Pneumothorax / epidemiology
Pyrimidines / adverse effects*
Retrospective Studies
Sarcoma / drug therapy*
Soft Tissue Neoplasms / drug therapy*
Sulfonamides / adverse effects*

Substances

Angiogenesis Inhibitors
Indazoles
Pyrimidines
Sulfonamides
pazopanib